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Abstract Mass methanol poisonings present a serious
problem for health systems worldwide, with poor outcome
associated with delayed treatment. Positive pre-hospital
serum ethanol concentration may have predictive value as
the prognostic factor of the treatment outcome. We studied
the effect of positive serum ethanol level on admission to
hospital on survival in patients treated during the Czech
methanol outbreak during 2012–2014. Cross-sectional
cohort study was performed in 100 hospitalized patients
with confirmed methanol poisoning. Pre-hospital ethanol
was administered in 42 patients (by paramedic/medical staff
to 30 patients and self-administered by 12 patients before
admission); 58 patients did not receive pre-hospital ethanol.
Forty-two patients had detectable serum ethanol concentra-
tion on admission to hospital [median 18.3 (IQR 6.6–32.2)
mmol dm-3]. Pre-hospital ethanol administration by
paramedic/medical staff had a significant effect on survival
without visual and CNS sequelae when adjusted for arterial
blood pH on admission (OR 8.73; 95 % CI 3.57–21.34;
p\ 0.001). No patients receiving pre-hospital ethanol died
compared with 21 not receiving (p\ 0.001). Positive serum
ethanol concentration on admission to hospital was a pre-
dictor for survival without health sequelae when adjusted for
arterial blood pH (OR 8.10; 95 % CI 2.85–23.02;
p\ 0.001). The probability of visual and CNS sequelae in
survivors reduced with increasing serum ethanol concen-
tration on admission.
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Introduction
Mass and cluster acute methanol poisonings due to the
consumption of illicit alcohol occur frequently throughout
the world [1–4]. Sporadic methanol poisonings occur either
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intentionally through the abuse of methanol-containing
fluids or attempted suicide or unintentionally through the
misuse or occupational accident with products containing
methanol as a solvent [5–7]. In the absence of protective
ethanol concentration in blood serum, methanol is metab-
olized by hepatic alcohol dehydrogenase enzyme (cytosolic
ADH1) to the highly toxic formic acid, which inhibits
mitochondrial respiration [8, 9]. The accumulation of for-
mic acid leads to the metabolic acidosis with anion gap
increase, optic nerve and retinal nerve fibers damage, and
necrosis of basal ganglia [10–13]. Ethanol as an antidote
prevents the toxic metabolite formation by competitive
blocking the ADH; therefore, its timely administration is
important for successful treatment [14].
Ethanol has 10–12 times higher affinity for ADH than
methanol and its serum concentration of
22–33 mmol dm-3 is sufficient to completely block the
metabolism of methanol to formaldehyde, and on the sec-
ond step to formate [15, 16]. In hospitals, the indications
for ethanol administration are either a documented plasma
methanol concentration of more than 6.2 mmol dm-3, a
high osmolal gap with documented the recent history of
ingesting toxic amounts of methanol, or a metabolic aci-
dosis with history or strong clinical suspicion of poisoning
[17, 18].
To prevent high morbidity and mortality of methanol
poisoning, ethanol should be administered as soon as
possible after methanol ingestion [14, 19]. Its wide
availability in the community makes it suitable antidote
for a pre-hospital ‘first aid’ in the cases of suspicious
toxic alcohol ingestion. We addressed this question
during a recent methanol mass poisoning in the Czech
Republic [20, 21]. In this study, we aimed to evaluate
serum ethanol concentration on admission to hospital as
the factor predictive of treatment outcome in patients
with acute methanol poisoning during a methanol
epidemic.
Results and discussion
During the Czech mass methanol poisoning outbreak in
2012–2014, 137 patients were poisoned and 106 of them
were treated in hospitals. Of them, blood samples for serum
ethanol measurement were not taken before hospital anti-
dote treatment with intravenous ethanol, in six patients.
Since serum ethanol concentration on admission before
hospital treatment was the key variable for the study, these
six patients were excluded from further analysis. The
patients who died outside hospital (n = 31) were excluded
from the study. Thus, 100 patients with median age 54
(interquartile range, IQR 38–61) years, 79 males and 21
females, were included in the study.
The administration of pre-hospital ethanol was identified
in detailed histories taken on admission by research staff
(corroborated by the laboratory analysis). Thirty patients
received pre-hospital ethanol from medical or paramedical
staff and twelve patients self-administered ethanol shortly
before admission to hospital. The remaining 58 patients did
not receive pre-hospital ethanol from any sources before
presentation.
Demographic and laboratory admission data are pre-
sented in Table 1, separated according to outcome.
Severity of metabolic acidosis in the patients on admission
to hospital is characterized by arterial blood pH, pCO2,
HCO3-, base deficit (BD), anion gap (AG), and serum
lactate (Table 2). Data are presented as medians with IQR,
because serum methanol, ethanol (EtOH), and osmolal gap
(OG) in all groups, pH and lactate in Group I, and pCO2
and AG in Group III were not normally distributed. Forty-
two patients had detectable ethanol before hospital antidote
treatment, with a median concentration of
18.3 mmol dm-3 (IQR 6.6–32.2 mmol dm-3). The median
serum ethanol on admission in the patients with pre-hos-
pital administration by paramedics/medical staff was
18.3 mmol dm-3 (IQR 7.1–28.1 mmol dm-3). The median
serum ethanol on admission in the patients with pre-hos-
pital self-administration was higher: 30.6 mmol dm-3
(6.4–81.9 mmol dm-3). The serum methanol concentration
on admission in EtOH-positive patients did not statistically
differ from that in EtOH-negative patients; however, they
were less acidotic and had lower serum glucose concen-
tration on admission.
Clinical features on admission included visual and gas-
trointestinal disturbances, dyspnea, chest pain, and coma in
most severely poisoned patients (Table 3). Other features
included fatigue, headache, dizziness, somnolence, anxiety,
alcoholic delirium, tremor, seizures, and cardiac and respi-
ratory arrest. The median ethanol concentration was higher
in patients without clinical symptoms on admission
[10.9 mmol dm-3 (1.1–29.8 mmol dm-3)] than in those
with clinical features [0 mmol dm-3 (0–5 mmol dm-3);
p = 0.014]. Detailed information about the post-admission
treatment given in hospitals is presented in Table 4.
Outcome and prognosis
EtOH-positive patients had a lower rate of mortality and a
higher rate of survival without visual and CNS sequelae
than EtOH-negative patients (all p\ 0.001; Table 5).
A strong positive correlation was found between the pre-
hospital ethanol administration by paramedics/medical
staff and serum ethanol concentration on admission
(r = 0.713, p\ 0.001). Furthermore, strong positive cor-
relations were found between the serum ethanol on
admission and:
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(a) survival versus death (r = 0.418, p\ 0.001);
(b) survival without sequelae versus poor outcome (death
or survival with sequelae; r = 0.711, p\ 0.001); and
(c) survival without sequelae versus survival with sequelae
versus death (r = 0.693, p\ 0.001).
These correlations were strong and significant for the
variable ‘‘pre-hospital ethanol administration by para-
medics/medical staff’’ for all three variants of outcome
division as well (r = 0.338; r = 0.537; and r = 0.531,
respectively; all p\ 0.001). In spite of the fact that there
was no difference in the state-of-consciousness on the
arrival of paramedics/medical staff, most of the patients
with Glasgow coma scale (GCS) under 10 were not
administered ethanol. Even after excluding the patients
with low GCS (under 10) from the analyzed data set, the
association remained significant:
(a) survival versus death (r = 0.355; p = 0.001);
(b) survival without sequelae versus poor outcome (death
or survival with sequelae; r = 0.689, p\ 0.001); and
(c) survival without sequelae versus survival with sequelae
versus death (r = 0.681; p\ 0.001).
In the univariate analysis, both serum ethanol concen-
tration on admission and pre-hospital ethanol
administration by paramedics/medical staff were signifi-
cant variables for survival without sequelae (Table 6). In
the bivariate regression models, the combinations of either
variable, ‘‘serum ethanol on admission’’, and ‘‘pre-hospital
ethanol administration’’ with the variable ‘‘arterial blood
pH on admission’’ explained 55.4 and 48.9 % of dispersion
in treatment outcomes, respectively (Table 7).
The patients with positive serum ethanol on admission
had the odds ratio of survival without sequelae versus poor
outcome (death or sequelae) of 8.10 (2.85–23.02 95 % CI;
p\ 0.001) when adjusted on the degree of acidemia (ar-
terial blood pH on admission).





















































































































Group III (n = 21) EtOH?
(n = 0)































P(EtOH? vs. EtOH-) 0.185 0.090 0.068 \0.001*** 0.005** 0.202 \0.001***
PI(EtOH? vs. EtOH-) 0.212 0.636 0.459 0.883 0.093 0.151 0.220
PII(EtOH? vs. EtOH-) 0.070 0.266 0.643 0.250 – 0.706 0.848
PI–II 0.581 0.030* 0.004** \0.001*** 0.044* 0.013* 0.041*
PI–III 0.255 0.005** 0.080 \0.001*** 0.202 0.015* \0.001***
PII–III 0.138 0.351 0.204 \0.001*** 0.924 0.541 0.015*
EtOH?, patients with pre-hospital ethanol administration by paramedics/medical staff; EtOH-, patients without pre-hospital ethanol administration by
paramedics/medical staff; Group I, survivors without sequelae; Group II, survivors with sequelae; Group III, died, IQR, interquartile range
PI, PII, PIII—results of t test (two-sample assuming equal and unequal variances, respectively) of difference in laboratory parameters between the
subgroups of patients with and without pre-hospital ethanol administration in Groups I, II, and III [* a B 0.05; ** a B 0.01; *** a B 0.001 (a-
significance level)]. To convert from mmol dm-3 to mg 0.1 dm-3, use the following conversion factors: methanol—3.205; ethanol—4.608; formate—
4.603; glucose—18.018
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Furthermore, the patients with pre-hospital ethanol
administration by paramedics/medical staff had the odds
ratio of survival without sequelae versus poor outcome
(death or sequelae) of 8.73 (3.57–21.34 95 % CI;
p\ 0.001) when adjusted on arterial blood pH on admis-
sion. Inclusion of any other independent variable in the
logistic regression model did not lead to further increase of
its ability to explain the dispersion in treatment outcomes.
The univariate and bivariate regression models for three
variants of treatment outcome analyzed separately (survival
without sequelae versus survival with sequelae versus death)
are presented on Fig. 1. Serum ethanol concentration on
admission, severity of metabolic acidosis, and pre-hospital
ethanol administration (‘‘first aid’’) are the most significant
variables for the outcome of treatment.
The logistic regression of probability of death or survival
with sequelae versus concentration of serum ethanol and arterial
blood pH on admission is shown in Fig. 2. The probability of
death decreased exponentially with the increase of arterial blood
pH. All who died had negative serum ethanol on admission;
however, the probability of developing sequelae among the
survivors was dependent not only on the degree of acidemia, but
also on the serum ethanol concentration on admission, with a
significant leftward shift of the peak of the curve. This implies
that an increasing ethanol concentration was protective against
visual and CNS damage given the same arterial blood pH. For
example, the patients with arterial blood pH 7.0: the probability
of developing sequelae was 59 % (negative serum ethanol)
versus 41 % (serum ethanol\11 mmol dm-3) versus 16 %
(serum ethanol[11 mmol dm-3).
Table 2 Severity of metabolic acidosis on admission in hospitalized patients, according to the outcome groups (medians with IQR)
















































































Group III (n = 21) EtOH? (n = 0) – – – – – –
























P(EtOH? vs. EtOH-) \0.001*** 0.587 \0.001*** \0.001*** \0.001*** \0.001***
PI(EtOH? vs. EtOH-) 0.373 0.759 0.300 0.905 0.418 0.449
PII(EtOH? vs. EtOH-) 0.601 0.976 0.939 0.961 0.666 0.991
PI–II \0.001*** \0.001*** \0.001*** \0.001*** \0.001*** 0.111
PI–III \0.001*** 0.181 \0.001*** \0.001*** \0.001*** \0.001***
PII–III \0.001*** 0.041* 0.401 0.012* 0.042* \0.001***
EtOH?, patients with pre-hospital ethanol administration by paramedics/medical staff; EtOH-, patients without pre-hospital ethanol admin-
istration by paramedics/medical staff; pH. arterial blood pH on admission; HCO3-, arterial blood bicarbonate on admission; Group I, survivors
without sequelae; Group II survivors with sequelae; Group III, died; IQR, interquartile range
PI, PII, PIII—results of t test (two-sample assuming equal and unequal variances, respectively) of difference in laboratory parameters between the
subgroups of patients with and without pre-hospital ethanol administration in Groups I, II, and III [* a B 0.05; ** a B 0.01; *** a B 0.001 (a-
significance level)]. To convert serum lactate from mmol dm-3 to mg 0.1 dm-3, use the conversion factor 9.009. To convert bicarbonate and
base deficit from mmol dm-3 to mEq dm-3, use the conversion factor 1.0. To convert kPa to mmHg (torr), use the conversion factor 7.501
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16 (59 %) 4 (15 %) 7 (26 %) 1 (4 %) 1 (4 %) 0 (0 %) 0 (0 %)
EtOH-
(n = 22)





1 (33 %) 3 (100 %) 2 (67 %) 1 (33 %) 0 (0 %) 0 (0 %) 1 (33 %)
EtOH-
(n = 27)










17 (57 %) 7 (23 %) 9 (30 %) 2 (7 %) 1 (3 %) 0 (0 %) 1 (3 %)
EtOH-
(n = 70)
6 (9 %) 30 (43 %) 36 (51 %) 29 (41 %) 9 (13 %) 3 (4 %) 27 (39 %)






























































EtOH?, patients with pre-hospital ethanol administration by paramedics /medical staff; EtOH-, patients without pre-hospital ethanol admin-
istration by paramedics/medical staff; Group I, survivors without sequelae; Group II, survivors with sequelae; Group III, died, VD, visual
disturbances; GI, gastrointestinal symptoms, D, dyspnea, CP, chest pain, C, coma, RA, respiratory arrest
Chi2-test [* a B 0.05; ** a B 0.01; *** a B 0.001 (a-significance level)]
Table 4 Treatment given in hospitalized patients according to the outcome groups
Alkalization Ethanol Fomepizole Folates CVVHD/CVVHDF IHD
Group I (n = 49) EtOH?
(n = 27)
8 (30 %) 21 (78 %) 6 (22 %) 20 (74 %) 10 (37 %) 8 (30 %)
EtOH-
(n = 22)
12 (55 %) 19 (86 %) 2 (9 %) 19 (86 %) 7 (32 %) 9 (41 %)
Group II (n = 30) EtOH?
(n = 3)
2 (67 %) 2 (67 %) 2 (67 %) 2 (67 %) 1 (33 %) 1 (33 %)
EtOH-
(n = 27)
25 (93 %) 18 (67 %) 8 (30 %) 22 (81 %) 13 (48 %) 12 (44 %)
Group III (n = 21) 20 (95 %) 16 (76 %) 7 (33 %) 13 (62 %) 15 (71 %) 5 (24 %)
Total (n = 100) EtOH?
(n = 30)
10 (33 %) 23 (77 %) 8 (27 %) 22 (73 %) 11 (37 %) 9 (30 %)
EtOH-
(n = 70)
57 (81 %) 53 (76 %) 17 (24 %) 54 (77 %) 35 (50 %) 26 (37 %)




























































EtOH?, patients with pre-hospital ethanol administration by paramedics/medical staff; EtOH-, patients without pre-hospital ethanol admin-
istration by paramedics/medical staff; Group I, survivors without sequelae; Group II, survivors with sequelae; Group III, died; CVVHD/HDF,
continuous veno-venous hemodialysis/hemodiafiltration; IHD, intermittent hemodialysis
Chi2 test [* a B 0.05; ** a B 0.01; *** a B 0.001 (a-significance level)]
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The logistic regression of probability of poor out-
come (death or sequelae) in the patients with pre-
hospital ethanol administration by the paramedics/
medical staff versus probability in the patients with-
out pre-hospital ethanol administration is shown in
Fig. 3.
Serum ethanol on admission and prognostic
parameters of treatment outcome
The poor outcome in methanol poisonings is primarily
associated with the late diagnosis and delayed initiation of
treatment with antidote, be it fomepizole or ethanol [22–24].
Severity of metabolic acidosis on admission is known
prognostic parameter of poor outcome (death or long-term
visual and/or central nervous system sequelae) in acute
methanol poisoning [25–28]. Timely correction of acidemia
and the elimination of formic acid by hemodialysis are one of
the crucial issues for successful treatment [29–33].
In our study, the EtOH-positive patients were less aci-
dotic on admission to hospitals with significantly higher
arterial blood pH and bicarbonate, and lower lactate, base
deficit, and anion gap, with no difference in time to pre-
sentation or serum methanol on admission as compared with
the EtOH-negative patients. This indicates an effective
blocking of the ADH enzyme in the pre-treated patients. The
pre-hospital ethanol group was still able to hyperventilate
adequately in spite of the ethanol treatment indicating that a
modest administration of ethanol itself does not alter the
patients’ ability to hyperventilate, and thus not removing this
important compensatory mechanism [34, 35].
There were significantly more asymptomatic patients on
admission to hospitals in the EtOH-positive group. In Group
I (survivors without sequelae), there were also fewer patients
Table 5 Pre-hospital administration of ethanol versus outcomes of acute methanol poisonings (n = 100)
Group I: survived without sequelae Group II: survived with sequelae Group III: died
Pre-hospital ethanol administered by
paramedics/medical staff (n = 30)
27 (90.0 %) 3 (10.0 %) 0 (0.0 %)
Pre-hospital ethanol not given by
paramedics/medical staff (n = 70)









Pre-hospital ethanol, including self-
administration (n = 42)
38 (90.5 %) 4 (9.5 %) 0 (0.0 %)









Chi2-test [* a B 0.05; ** a B 0.01; *** a B 0.001 (a-significance level)]
Table 6 Parameters of the univariate analysis significant for survival without sequelae
Intercept b SE OR LE 95 % CI UE 95 % CI p Cox and Snell R2 Nagelkerke R2 Hosmer–
Lemeshow R2
S-EtOH -6.319 2.576 0.504 13.139 4.892 35.291 0.000 0.439 0.586 0.417
pH -4.013 2.253 0.411 9.515 4.249 21.308 0.000 0.405 0.540 0.375
HCO3- -2.839 1.527 0.284 4.602 2.637 8.033 0.000 0.321 0.427 0.279
‘‘First aid’’ -2.197 2.977 0.661 19.636 5.378 71.703 0.000 0.273 0.365 0.230
GCS -2.086 1.556 0.441 4.742 1.997 11.258 0.000 0.141 0.189 0.110
S-MetOH -1.841 0.941 0.279 2.563 1.485 4.425 0.001 0.122 0.162 0.094
Time -1.917 1.068 0.352 2.910 1.459 5.804 0.002 0.115 0.153 0.088
S-Lactate -1.396 0.933 0.332 2.541 1.325 4.873 0.005 0.105 0.142 0.082
OR, odds ratio; LE 95 % CI, lower endpoint of 95 % confidence interval; UE 95 % CI, upper endpoint of 95 % confidence interval; ‘‘First aid’’,
pre-hospital ethanol administration by paramedics/medical staff; pH, arterial blood pH on admission;HCO3-, arterial blood bicarbonate on
admission; GCS, Glasgow coma scale; S-EtOH, serum ethanol on admission; S-MetOH, serum methanol on admission; S-Lactate, serum lactate
on admission; Time, time span between methanol ingestion and the treatment
Bold value indicates statistically significant p values (p\ 0.05)
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with dyspnea and symptoms of visual toxicity at presenta-
tion among the EtOH-positive patients comparing the EtOH-
negative patients. Only one patient administered pre-hospital
ethanol with GCS 10 fell into a coma on admission to the
hospital; this patient had severe acidemia on admission to
hospital with high serum lactate and low methanol, sug-
gesting that most of it had already been metabolized to toxic
formic acid. In other patients who received pre-hospital
ethanol administration, no deterioration of the state-of-con-
sciousness was registered after admission.
The significant association was found between the out-
come of treatment and both serum ethanol concentration on
admission and pre-hospital ethanol administration by
paramedics/medical staff in our study. The positive asso-
ciation remained strong after the elimination of patients
with GCS B10 on the first presentation. Logistic regression
analysis demonstrated that serum ethanol concentration on
admission was significant variable for the treatment out-
come when adjusted for the degree of acidemia and the
state-of-consciousness on admission.
The probability of poor outcome (death or sequelae)
decreased exponentially with increasing arterial blood pH,
but the rate of decrease was higher in the patients with pre-
hospital ethanol administration. Finally, the probability of
survival with visual and/or CNS sequelae depended on the
serum ethanol concentration.
In summary, the present data document the significant
association between positive serum ethanol concentration
on admission to hospital and better treatment outcome in
acute methanol poisoning. This fact supports the recom-
mendation on the potential benefit of the pre-hospital
administration of ethanol on outcome during an on-going
outbreak of methanol poisoning [21]: given a standard
regimen, a worst-case scenario would mean that a certain
number of patients will be given a limited amount of
ethanol unnecessarily, which can be considered accept-
able from a risk–benefit point of view.
Strength and limitations
The limitations of this study can be attributed to certain
confounders, as it was not a randomized controlled trial,
leaving the possibility of inherent bias during the com-
parisons. The numbers of the patients in both groups were
relatively small (even if by far the largest of its kind), and
most of the patients in both groups were the so-called
‘‘late-presenters’’. Despite the limitations and confounders,
the study provides important data on the effect of positive
serum ethanol concentration on admission to hospital on
the outcome of treatment during a large methanol outbreak.
The essential clinical and laboratory data on admission
were collected during admission to hospital using stan-
dardized forms. The groups of patients were also
comparable by age, circumstances of poisoning, latency
period, and size.
Conclusion
In our study, positive serum ethanol concentration on
admission to hospital was associated with survival and
better treatment outcome of poisoned patients during the
Table 7 Bivariate logistic regression for pre-hospital ethanol/serum ethanol on admission and the parameters significant for survival without
sequelae
Intercept b1 SE1 p1 b2 SE2 p2 Adjusted
OR (exp b1)
LE 95 % CI UE 95 % CI Hosmer–
Lemeshow R2
pH First aid -5.894 2.166 0.456 0.000 2.725 0.809 0.001 8.726 3.567 21.344 0.489
HCO3- First aid -4.090 1.258 0.304 0.000 2.308 0.720 0.001 3.519 1.941 6.380 0.373
GCS First aid -4.101 2.868 0.685 0.000 1.458 0.523 0.005 17.595 4.593 67.404 0.299
S-MetOH First aid -4.139 2.974 0.698 0.000 0.972 0.333 0.004 19.562 4.978 76.877 0.296
S-Lactate First aid -3.914 3.434 0.824 0.000 0.913 0.411 0.027 30.989 6.158 155.943 0.349
Time First aid -4.027 2.857 0.709 0.000 1.075 0.412 0.009 17.415 4.342 69.843 0.288
pH S-EtOH -8.393 2.092 0.533 0.000 1.817 0.478 0.000 8.103 2.852 23.018 0.554
HCO3- S-EtOH -7.188 2.137 0.518 0.000 1.018 0.339 0.003 8.476 3.070 23.404 0.485
GCS S-EtOH -7.824 2.417 0.490 0.000 1.435 0.641 0.025 11.216 4.289 29.328 0.462
S-MetOH S-EtOH -8.130 2.554 0.534 0.000 0.933 0.378 0.014 12.863 4.514 36.660 0.461
OR, odds ratio; LE 95 % CI, lower endpoint of 95 % confidence interval; UE 95 % CI, upper endpoint of 95 % confidence interval; ‘‘First aid’’,
pre-hospital ethanol administration by paramedics/medical staff; ‘‘S-EtOH’’ - serum ethanol on admission; pH, arterial blood pH on admission;
HCO3-, arterial blood bicarbonate on admission; GCS, Glasgow coma scale; S-MetOH, serum methanol on admission; S-EtOH, serum ethanol
on admission; S-Lactate, serum lactate on admission; Time, time span between methanol ingestion and the treatment
Bold value indicates statistically significant p values (p\ 0.05)
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Czech mass methanol outbreak. Our data, therefore,
strongly support a recommendation that ethanol can be
administered pre-hospital by paramedics/medical staff to
conscious patients suspected to be poisoned with methanol
before laboratory data are available and diagnosis
confirmed.
Fig. 1 Percents of explained
dispersion in univariate and
bivariate ordinal multinomial
models for three categories of
treatment outcomes (survival
without sequelae versus survival
with sequelae versus death). For
the univariate models, see
parameters and per cents inside
the circles; for bivariate models,
see per cents on the lines
connecting parameters. S-EtOH,
serum ethanol concentration on
admission; pH, arterial blood
pH on admission; HCO3-,
arterial blood bicarbonate on
admission; ‘‘First aid’’, pre-
hospital ethanol administration
by paramedics/medical staff;
GCS, Glasgow coma scale;
S-Lactate, serum lactate on
admission; Time, time span
between methanol ingestion and






Fig. 2 Risk of death and
survival with sequelae versus
arterial blood pH and serum
ethanol on admission. Total
n = 100: died
(n = 21) ? survivors with
sequelae (n = 30) ? survivors
without sequelae (n = 49). S-
EtOH serum ethanol
concentration on admission




Among 137 cases of methanol poisoning in the Czech
Republic from the 3 September 2012 until the 31 August
2014, 106 patients were treated in hospitals. The discharge
reports of all hospitalized patients with a confirmed diag-
nosis and the results of neurological and ophthalmological
examinations on admission, during hospitalization, and on
discharge were collected and analyzed in the TIC. A
detailed history of the poisoning, and of the onset and
dynamics of ocular and systemic toxicity, was obtained in a
prospective manner directly from the patients or from rel-
atives of critically ill patients upon admission to the
secondary hospital.
Laboratory analyses were performed on admission. Diag-
nosis was established when (1) a history of recent ingestion of
illicit spirits was available and serum methanol was higher than
6.2 mmol dm-3 and/or an osmolal gap (OG) C20 mOsm (kg
H2O)
-1 was found, or (2) there was a history/clinical suspicion
of methanol poisoning, and serum methanol was above the
limit of detection with at least two of the following: pH\7.3,
serum bicarbonate \20 mmol dm-3, and anion gap
(AG) C20 mmol dm-3 [36, 37].
The clinical examination protocol included complete
ocular examination with the standard ophthalmologic tests
(visual acuity, color vision, contrast sensitivity, perimeter,
and fundus), cerebral computed tomography (CT) or
magnetic resonance imaging (MRI) of the brain, and
standard neurological examination. The patients were
considered to have visual sequelae of acute methanol poi-
soning if the symptoms of toxic neuropathy of the optic
nerve were documented on admission/during hospitaliza-
tion, with pathologic findings on visual acuity, visual fields,
color vision, contrast sensitivity, and persisting lesions on
fundoscopy with other symptoms of visual damage being
found on discharge from the hospitals. The patients were
considered as having CNS sequelae of poisoning if sym-
metrical necrosis and hemorrhages of basal ganglia were
present on CT or MRI of the brain.
The hospitalized patients were retrospectively divided
into three groups according to their outcome: Group I:
Patients who survived without sequelae; Group II: patients
who survived with visual and/or CNS sequelae; and Group
III: patients who died. These groups were then further
divided into two subgroups ‘with pre-hospital ethanol
administration by paramedics/medical staff (EtOH-posi-
tive)’ and ‘without pre-hospital ethanol administration by
paramedics/medical staff (EtOH-negative)’. Within the
latter subgroup, the data from patients who self-adminis-
tered ethanol shortly before presentation to hospitals were
analyzed separately.
Treatment
All patients were treated in accordance to the American
Association of Clinical Toxicology and the European
Association of Poison Centres and Clinical Toxicologists
(AACT/EAPCCT) practice guidelines on the treatment
of methanol poisoning [14]. Bicarbonate 8.4 or 4.2 %
solution was given intravenously as a buffer to the
patients with metabolic acidosis. Fomepizole or ethanol
were administered as antidotes to block ADH enzyme.
Folates were administered to substitute the endogenous
pool.
Fig. 3 Risk of poor outcome
(death or sequelae) versus pre-
hospital ethanol administration
by paramedics/medical staff.
Total n = 100: poor outcome
[Group III (died);
n = 21 ? Group II (survivors
with sequelae); n = 30].
Favorable outcome [Group I
(survivors without sequelae);
n = 49]
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Enhanced elimination was performed if the patients met
any of the following criteria: serum methanol higher than
15.6 mmol dm-3, metabolic acidosis with arterial blood
pH\ 7.30, or had the signs of visual toxicity. The choice
of modality of enhanced elimination was based on several
factors, such as the hemodynamic stability of a patient on
admission, or the severity of poisoning, and availability of
dialysis equipment.
Laboratory investigations
Methanol was measured by a gas chromatographic method
with flame ionization detection and a direct injection with
an internal standard, limit of detection 1.9 mmol dm-3,
and day-to-day coefficient of variation 2.5–5.4 %. Formate
was measured enzymatically using formate dehydrogenase
and nicotinamide adenine dinucleotide, according to a
previously published method [38, 39]. Day-to-day coeffi-
cient of variation was 5.6 %, and the upper reference limit
was 0.44 mmol dm-3. Serum ethanol was analyzed by gas
chromatography with flame ionization detection and direct
injection with an internal standard. The limit of detection
was 0.87 mmol dm-3, and the day-to-day coefficient of
variation was 3.8–7.1 %. Osmolality was measured by the
freezing point depression method on a Fiske one-ten
osmometer. The reference range for the osmolal gap was
-9 to 19 mOsm (kg H2O)
-1 [40]. The osmolal contribu-
tion from ethanol was subtracted from the measured
osmolality.
Statistical analyses
The laboratory and clinical data were compared using two-
sample assuming unequal variances, two-sample F test for
variances, bias test, and two-sample Kolmogorov–Smirnov
test. The data were expressed as medians with interquartile
ranges (IQR). Spearman’s rank correlation, exploratory
factor analysis, and Chi-square tests were used to analyze
the association between different variables and the out-
comes of treatment. Statistically significant parameters
were subsequently used in the regression models of ordinal
multinomic logistic regression based on likelihood ratio
estimation. Probabilistic analysis of predictive ability of
significant parameters for the poor outcome of treatment
was applied using Hosmer–Lemeshow likelihood ratio R2.
All statistical calculations were carried out on the level of
significance a = 0.05.
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